Cargando…
CDK5 promotes apoptosis and attenuates chemoresistance in gastric cancer via E2F1 signaling
BACKGROUND: Chemoresistance is a major clinical challenge that leads to tumor metastasis and poor clinical outcome. The mechanisms underlying gastric cancer resistance to chemotherapy are still unclear. METHODS: We conducted bioinformatics analyses of publicly available patient datasets to establish...
Autores principales: | Cao, Long-Long, Wu, Yu-Kai, Lin, Tong-Xin, Lin, Mi, Chen, Yu-Jing, Wang, Ling-Qian, Wang, Jia-Bin, Lin, Jian-Xian, Lu, Jun, Chen, Qi-Yue, Tu, Ru-Hong, Huang, Ze-Ning, Lin, Ju-Li, Zheng, Hua-Long, Xie, Jian-Wei, Li, Ping, Huang, Chang-Ming, Zheng, Chao-Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664659/ https://www.ncbi.nlm.nih.gov/pubmed/37990321 http://dx.doi.org/10.1186/s12935-023-03112-4 |
Ejemplares similares
-
CDK5RAP3 acts as a tumour suppressor in gastric cancer through the infiltration and polarization of tumour-associated macrophages
por: Wang, Jia-Bin, et al.
Publicado: (2022) -
Low Expression of CDK5 and p27 Are Associated with Poor Prognosis in Patients with Gastric Cancer
por: Sun, Yu-Qin, et al.
Publicado: (2016) -
CDK5RAP3 Inhibits the Translocation of MCM6 to Influence the Prognosis in Gastric Cancer
por: Chen, Qi-Yue, et al.
Publicado: (2019) -
CDK5RAP3 suppresses Wnt/β-catenin signaling by inhibiting AKT phosphorylation in gastric cancer
por: Zheng, Chao-Hui, et al.
Publicado: (2018) -
Low expression of CDK5RAP3 and DDRGK1 indicates a poor prognosis in patients with gastric cancer
por: Lin, Jian-Xian, et al.
Publicado: (2018)